Recent Insider Transactions - ARS Pharmaceuticals (NASDAQ: SPRY)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ SPRY ARS Pharmaceuticals

Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO

08/21/2025

Sell

$14.49

50,000

$724K

1.20M

NASDAQ SPRY ARS Pharmaceuticals

Scott Kathleen D. / officer: Chief Financial Officer

08/21/2025

Sell

$1.50

12,500

$19K

739,830

NASDAQ SPRY ARS Pharmaceuticals

Scott Kathleen D. / officer: Chief Financial Officer

08/21/2025

Buy

$1.50

12,500

$19K

22,542

NASDAQ SPRY ARS Pharmaceuticals

Scott Kathleen D. / officer: Chief Financial Officer

08/21/2025

Sell

$15.00

12,500

$188K

10,042

NASDAQ SPRY ARS Pharmaceuticals

Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER

08/19/2025

Sell

$14.03

12,344

$173K

1.29M

NASDAQ SPRY ARS Pharmaceuticals

Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER

08/20/2025

Sell

$14.09

37,656

$531K

1.25M

NASDAQ SPRY ARS Pharmaceuticals

Karas Eric / officer: Chief Commercial Officer

07/01/2025

Sell

$1.50

15,000

$23K

544,588

NASDAQ SPRY ARS Pharmaceuticals

Karas Eric / officer: Chief Commercial Officer

07/01/2025

Buy

$1.50

15,000

$23K

25,315

NASDAQ SPRY ARS Pharmaceuticals

Karas Eric / officer: Chief Commercial Officer

07/01/2025

Sell

$16.99

15,000

$255K

10,315

NASDAQ SPRY ARS Pharmaceuticals

Flynn James E / 10 percent owner

06/27/2025

Sell

$18.46

370,074

$6.832M

4.89M